PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50322F80030Doxycycline hyclate tablets and amoxicillin — Chartwell Rx LLC

Chartwell Rx LLC holds $76.1M across 576 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award under parent 36F79720D0198. Competition previously drew 2 offers. Set-aside status: SBA. PoP ended Mar 23, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Aspr/Orm-Sns
Awarding office
Department of Health and Human Services (HHS)
Agency
Chartwell Rx LLC
Recipient
Mar 23, 2026
PoP end
$99M
Obligated
325412
NAICS
6505
PSC
SBA
Set-aside
2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

SBA
Contract number75A50322F80030
Also listed as36F79720D0198-75A50322F80030
AgencyDepartment of Health and Human Services (HHS)
Awarding officeAspr/Orm-Sns
IncumbentChartwell Rx LLC
UEIER5UA9TYBGH4
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79720D0198
Place of performanceCONGERS, NY
Related solicitation75A50122Q00018
PoP end (current)Mar 23, 2026
Obligated$99M

DOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES is a federal SBA award for Department of Health and Human Services (HHS) held by Chartwell Rx LLC. Estimated value $139.7M ($99M obligated). Current period of performance ends Mar 23, 2026. Last award drew 2 bidders. Place of performance: CONGERS, NY. Related solicitation 75A50122Q00018.

DOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES

Recompete timing

Public
● Past PoP end (191 days ago)

Current PoP ended Mar 23, 2026 (191 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75A50322F80030? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Chartwell Rx LLC — $76.1M obligated across 576 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($76.1M) · all agencies
Department of Health and Human Services (HHS)$74.1M · 97%Department of Defense (DOD)$1.9M · 2%
Open full company profile →

Related awards

Same parent · incumbent
75A50325F80009
DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS
Department of Health and Human Services (HHS) · CHARTWELL RX LLC
$98.7M
Jun 22, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50322F80030?

75A50322F80030 (Doxycycline hyclate tablets and amoxicillin) is a Aspr/Orm-Sns award with an estimated value of $139.7M, currently held by Chartwell Rx LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50322F80030?

Aspr/Orm-Sns awarded 75A50322F80030 to Chartwell Rx LLC.

Who is the incumbent on 75A50322F80030?

Chartwell Rx LLC is the incumbent with $76.1M across 576 related awards in SCOUT’s public footprint. The current period of performance ends Mar 23, 2026.

When does Chartwell Rx LLC’s 75A50322F80030 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 23, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50322F80030? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50322F80030